Cavalli, Giulio

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study

De Luca, G., Cavalli, G., Campochiaro, C., Della-Torre, E., Angelillo, P., Tomelleri, A., Boffini, N., Tentori, S., Mette, F., Farina, N., et al. (2020) · The Lancet Rheumatology

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 202

BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease

Cangi, M. G., Biavasco, R., Cavalli, G., Grassini, G., Dal-Cin, E., Campochiaro, C., Guglielmi, B., Berti, A., Lampasona, V., von Deimling, A., et al. (2015) · Annals of the Rheumatic Diseases

Histiocytic Disorders and TreatmentsSarcoidosis and Beryllium Toxicity Research

Cited by 112

Treating Life-Threatening Myocarditis by Blocking Interleukin-1*

Cavalli, G., Pappalardo, F., Mangieri, A., Dinarello, C. A., Dagna, L., & Tresoldi, M. (2016) · Critical Care Medicine

Viral Infections and Immunology ResearchMechanical Circulatory Support Devices

Cited by 96

Myocarditis: An Interleukin-1-Mediated Disease?

De Luca, G., Cavalli, G., Campochiaro, C., Tresoldi, M., & Dagna, L. (2018) · Frontiers in Immunology

Viral Infections and Immunology ResearchCardiac Fibrosis and Remodeling

Cited by 79

Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure

Cavalli, G., Foppoli, M., Cabrini, L., Dinarello, C. A., Tresoldi, M., & Dagna, L. (2017) · Frontiers in Immunology

Viral Infections and Immunology ResearchCardiac Fibrosis and Remodeling

Cited by 70

Treating Pulmonary Silicosis by Blocking Interleukin 1

Cavalli, G., Fallanca, F., Dinarello, C. A., & Dagna, L. (2015) · American Journal of Respiratory and Critical Care Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseases

Cited by 56

Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?

Benedetti, F., Mazza, M., Cavalli, G., Ciceri, F., Dagna, L., & Rovere-Querini, P. (2021) · Journal of Neuroimmune Pharmacology

Tryptophan and brain disordersLong-Term Effects of COVID-19

Cited by 55

Oncogene-Induced Senescence as a New Mechanism of Disease: The Paradigm of Erdheim–Chester Disease

Cavalli, G., Biavasco, R., Borgiani, B., & Dagna, L. (2014) · Frontiers in Immunology

Histiocytic Disorders and TreatmentsTelomeres, Telomerase, and Senescence

Cited by 50

Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis

Biavasco, R., Lettera, E., Giannetti, K., Gilioli, D., Beretta, S., Conti, A., Scala, S., Cesana, D., Gallina, P., Norelli, M., et al. (2021) · Nature Communications

Histiocytic Disorders and TreatmentsTelomeres, Telomerase, and Senescence

Cited by 47

Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition

De Luca, G., Campochiaro, C., Dinarello, C. A., Dagna, L., & Cavalli, G. (2018) · Annals of Internal Medicine

Cardiac Fibrosis and RemodelingViral Infections and Immunology Research

Cited by 42